Literature DB >> 24323379

A model of rat embolic cerebral infarction with a quantifiable, autologous arterial blood clot.

Norihito Shimamura1, Naoya Matsuda, Kiyohide Kakuta, Akiko Narita, Hiroki Ohkuma.   

Abstract

We developed a novel model of a rat embolic cerebral infarction with a quantifiable autologous arterial blood clot. The left femoral artery had 0.15 ml of blood withdrawn and mixed with 10 units of thrombin in 50 μl saline. After 30 min, the clot was suctioned into a 4-French polyvinyl chloride tube. A 24-gage catheter was inserted up through the internal carotid artery via the external carotid artery stump. The 1-cm clot, at a volume of 7.2 mm3, was pushed and inserted into the internal carotid artery via the catheter. After withdrawing the catheter, the ICA blood flow recovered. We checked neurological status after 24 h (neurological free was 15, and worst was 1) and measured the infarction volume by the TTC method. Twelve rats were examined, and five sham-operated rats were included. Two rats were not able to achieve an 80% reduction in CBF. One rat died due to cerebral infarction. The success rate in producing infarction was 83%. The total infarction volume was 368.5 mm3±61.2 se. Median neurological score was 6. Hemorrhagic transformation was not detected. Sham-operated rats revealed no infarction and no neurological deficit. The volume of infarction correlated significantly with the neurological score. We conclude that this embolic stroke model is useful in producing a human, severe cardioembolic cerebral infarction.

Entities:  

Mesh:

Year:  2013        PMID: 24323379     DOI: 10.1007/s12975-013-0262-5

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  19 in total

1.  A mouse model of embolic focal cerebral ischemia.

Authors:  Z Zhang; M Chopp; R L Zhang; A Goussev
Journal:  J Cereb Blood Flow Metab       Date:  1997-10       Impact factor: 6.200

2.  A simple in vivo atrial fibrillation model of rat induced by transesophageal atrial burst pacing.

Authors:  Atsushi Sugiyama; Akira Takahara; Sachiko Honsho; Yuji Nakamura; Keitaro Hashimoto
Journal:  J Pharmacol Sci       Date:  2005-06-19       Impact factor: 3.337

3.  An animal model of cerebral infarction. Homologous blood clot emboli in rats.

Authors:  M Kudo; A Aoyama; S Ichimori; N Fukunaga
Journal:  Stroke       Date:  1982 Jul-Aug       Impact factor: 7.914

4.  A new model of temporary focal neocortical ischemia in the rat.

Authors:  A M Buchan; D Xue; A Slivka
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

5.  A rat model of reproducible cerebral infarction using thrombotic blood clot emboli.

Authors:  K Overgaard; T Sereghy; G Boysen; H Pedersen; S Høyer; N H Diemer
Journal:  J Cereb Blood Flow Metab       Date:  1992-05       Impact factor: 6.200

6.  Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model.

Authors:  Norihito Shimamura; Gerald Matchett; Hiroshi Yatsushige; John W Calvert; Hiroki Ohkuma; John Zhang
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.

Authors:  T Sereghy; K Overgaard; G Boysen
Journal:  Stroke       Date:  1993-11       Impact factor: 7.914

9.  Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.

Authors:  K Overgaard; T Sereghy; G Boysen; H Pedersen; N H Diemer
Journal:  Scand J Clin Lab Invest       Date:  1993-07       Impact factor: 1.713

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  3 in total

1.  Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis.

Authors:  Kiyoshi Kikuchi; Kentaro Setoyama; Ko-Ichi Kawahara; Tomoka Nagasato; Takuto Terashi; Koki Ueda; Kazuki Nakanishi; Shotaro Otsuka; Naoki Miura; Hisayo Sameshima; Kazuya Hosokawa; Yoichiro Harada; Binita Shrestha; Mika Yamamoto; Yoko Morimoto-Yamashita; Haruna Kikuchi; Ryoji Kiyama; Chinatsu Kamikokuryo; Salunya Tancharoen; Harutoshi Sakakima; Motohiro Morioka; Eiichiro Tanaka; Takashi Ito; Ikuro Maruyama
Journal:  Oxid Med Cell Longev       Date:  2017-11-10       Impact factor: 6.543

Review 2.  Development and Testing of Thrombolytics in Stroke.

Authors:  Dmitri Nikitin; Seungbum Choi; Jan Mican; Martin Toul; Wi-Sun Ryu; Jiri Damborsky; Robert Mikulik; Dong-Eog Kim
Journal:  J Stroke       Date:  2021-01-31       Impact factor: 6.967

3.  Uric acid enhances alteplase-mediated thrombolysis as an antioxidant.

Authors:  Kiyoshi Kikuchi; Kentaro Setoyama; Eiichiro Tanaka; Shotaro Otsuka; Takuto Terashi; Kazuki Nakanishi; Seiya Takada; Harutoshi Sakakima; Sumate Ampawong; Ko-Ichi Kawahara; Tomoka Nagasato; Kazuya Hosokawa; Yoichiro Harada; Mika Yamamoto; Chinatsu Kamikokuryo; Ryoji Kiyama; Motohiro Morioka; Takashi Ito; Ikuro Maruyama; Salunya Tancharoen
Journal:  Sci Rep       Date:  2018-10-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.